Bone Biologics (BBLG) EBITDA (2007 - 2026)
Bone Biologics (BBLG) EBITDA from Oct 31, 2007 to Mar 31, 2026. The TTM Bone Biologics (BBLG) EBITDA is -$2.86M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Bone Biologics (BBLG) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -32.86% |
| 3 Years TTM | -14.28% |
| 5 Years TTM | +11.63% |
| 10 Years TTM | -16.63% |
| All Time TTM | +38.38% |
Annual EBITDA change of Bone Biologics (BBLG)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$770K | -75.24% |
| 2025 | -$3.11M | -24.33% |
| 2024 | -$4.11M | -54.08% |
| 2023 | -$8.95M | +504.73% |
| 2022 | -$1.48M | -8.07% |
| 2021 | -$1.61M | -11.54% |
| 2020 | -$1.82M | -25.71% |
| 2019 | -$2.45M | -12.19% |
| 2018 | -$2.79M | +6.08% |
| 2017 | -$2.63M | -87.11% |
| 2016 | -$20M | +70.23% |
| 2015 | -$12M | +298.34% |
| 2014 | -$3.01M | +30000.00% |
| 2013 | -$10K | N/A |
| 2012 | -$10K | N/A |
| 2011 | $0 | N/A |
| 2010 | $0 | -100.00% |
| 2009 | -$10K | N/A |
| 2008 | -$10K | -50.00% |
| 2007 | -$20K | N/A |
Comparison Bone Biologics (BBLG) five years EBITDA CAGR with competitors
Bone Biologics (BBLG) five years EBITDA CAGR is 11.48%.